2014 Scientific Meeting of the National Antimicrobial Resistance Monitoring System (NARMS)
August 12-13, 2014

Tuesday, August 12, 2104

8:00-8:15 Arrival
8:15-8:30 Welcome and Introductions - Bernadette Dunham, FDA-CVM and Stephen Ostroff, FDA-OC
8:30-8:45 Overview of agenda - Patrick McDermott, FDA-CVM

Session I: AMR Activities in the Federal Government

Moderator - Patrick McDermott, FDA-CVM

8:45-9:10  Food and Drug Administration (FDA) - William Flynn, FDA-CVM
9:10-9:35  Centers for Disease Control and Prevention (CDC) - Steve Solomon, CDC
9:35-10:00 United States Department of Agriculture (USDA) - Steven Kappes, USDA-ARS

Session II: NARMS Overview

Moderators - Emilio Esteban, USDA-FSIS and Robert Tauxe, CDC

10:00-10:30 NARMS progress report - Patrick McDermott, FDA-CVM
10:30-10:40 Break
10:40-11:40 How NARMS is used by public health partners

• (10:40-11:00) FDA perspective - Heather Harbottle, FDA-CVM 
• (11:00-11:20) CDC perspective - Barbara Mahon, CDC
• (11:20-11:40) USDA perspective - Joseph Hill, USDA-FSIS

11:40-12:00 NARMS human isolate surveillance - Regan Rickert-Hartman, CDC
12:00-12:30 NARMS retail isolate surveillance – Emily Crarey, FDA-CVM
12:30-1:00 NARMS animal isolate surveillance – Joseph Hill, USDA-FSIS
1:00-2:00 Lunch

Session III: Improvements in data acquisition, analysis, and reporting

Moderator - Regan Rickert-Hartman, CDC

2:00-2:30 CDC database and SAP Crystal Dashboard Design graphs - Jean Whichard, CDC
2:30-3:00 NARMS interagency database, FDA data for public access, and Tableau graphs - Michael Grabenstein and Claudine Kabera, FDA-CVM
3:00-3:20 The new Integrated NARMS Report and interim Salmonella reporting – Heather Tate, FDA-CVM 
3:20-3:30 Break

Session IV: International Collaborations

Moderator - Ruby Singh, FDA-CVM

3:30-4:00 Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) - Steve Solomon, CDC
4:00-4:30 World Health Organization Advisory Group on Integrated Surveillance of Antimicrobial Resistance (WHO-AGISAR)
- Beth Karp, CDC
4:30-5:00 Breakpoint–setting studies and European Committee on Antimicrobial Susceptibility Testing (EUCAST) synergies - Maria Karlsson, CDC

Wednesday, August 13, 2104

8:00-8:15 Overview of agenda - Patrick McDermott, FDA-CVM

Session V: Research

Moderator - T.B.D

8:15-9:00 How NARMS research aligns with Agency goals

• (8:15-8:30) FDA - David White, FDA-OC 
• (8:30-8:45) CDC - Barbara Mahon, CDC 
• (8:45-9:00) USDA - Eileen Thacker, USDA-ARS 

Microbiology

Moderators - Joseph Hill, USDA-FSIS and Jean Whichard, CDC

9:00-9:20 On-farm pilots - Eileen Thacker, USDA-FSIS
9:20-9:40 Antimicrobial drug resistance in historical E. coli and Salmonella from humans and food animals, United States, 1950s–2000s - Daniel Tadesse, FDA-CVM
9:40-10:00 Feed surveys - Beilei Ge, FDA-CVM
10:00-10:10 Break
10:10-10:30 Detecting emerging and novel gentamicin resistance genes in C. jejuni/coli using whole genome sequencing - Shaohua Zhao, FDA-CVM
10:30-10:50 Characterization of bla-CMY plasmids and identification of sources for foodborne outbreaks and sporadic illness caused by Salmonella - Jason Folster, CDC

Epidemiology

Moderators - Barbara Mahon, CDC and Heather Tate, FDA-CVM

10:50-11:10 Using antibiotic resistance data to understand food sources of enteric infections - Allison Brown, CDC
11:10-11:30 Clinical outcomes of antibiotic-resistant Salmonella infections - Beth Karp, CDC
11:30-11:50 Nalidixic acid-resistant Salmonella Enteritidis linked to international travel and imported foods - Allison O’Donnell, CDC and Claudine Kabera, FDA-CVM
11:50-12:10 Trends in antimicrobial resistance among Salmonella, 1996-2012 - Felicita Medalla, CDC
12:10-12:30 On-farm antimicrobial drug use and resistance: Results from recent National Animal Health Monitoring System (NAHMS) studies - David Dargatz, USDA-APHIS
12:30-1:30 Lunch

Session VI: Looking into the Future

Moderators - Robert Tauxe, CDC and Shaohua Zhao, FDA-CVM

1:30-2:00 Gathering antimicrobial use data in animals: the missing link - Craig Lewis, FDA-CVM
2:00-2:30 Whole genome sequencing: A food safety perspective - Ruth Timme, FDA-CFSAN
2:30-3:00 Comparing resistance genotypes with phenotypes- building a resistance gene library - Yuansha Chen, FDA-CVM
3:00-3:30 Looking into the future: Culture-independent diagnostics and opportunities to expand NARMS surveillance - Barbara Mahon and Jean Whichard, CDC
3:30-3:45 Break

Session VII: Public Comment Period

Moderator - Patrick McDermott

3:45-4:45 Public comments
4:45-5:00 Wrap Up - Patrick McDermott, FDA-CVM